Ovid Therapeutics Inc
OVID
$2.26+3.20%
End of day · as of Oct 16, 2026, 9:00 AM ET
Mkt cap
$23.46M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$7.25M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-240.13%
Beta
0.07
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported OVID revenue for 2025-12-31 was $7.3M. Net income was -$17.4M. Revenue was up 1181.3% from 2024-12-31 to 2025-12-31. OVID currently screens at market cap $23.5M.
Use this OVID research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full OVID income, balance, and cash tables.
Ovid Therapeutics Inc (OVID) is a biotechnology company in the Healthcare sector.
Latest cached Ovid Therapeutics Inc (OVID) revenue for Dec 31, 2025 was $7.3M. Net income was -$17.4M. Statements: https://lician.com/financials/ovid
Ovid Therapeutics Inc (OVID) market capitalization is $23.5M on the latest cached snapshot.
Ovid Therapeutics Inc (OVID) cached previous close $2.19; day range $2.21 – $2.26; volume 1,333,088. Session quote: https://lician.com/quote/ovid
Ovid Therapeutics Inc (OVID) latest cached earnings event is "OVID earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings